Nucleic acid nanoparticles for analyte detection

Aleksei Aksimentiev (Inventor), Kirill A Afonin (Inventor), Meni Wanunu (Inventor)

Research output: Patent


Provided is a highly multiplex approach to disease condition diagnostics that combines nanopore sensing and nucleic acid nanoparticle (NANP) design and synthesis to detect multiple biomarkers to diagnose diseases. The system works by taking a sample containing biomarkers that is mixed with a plurality of nucleic acid nanoparticle (NANP) populations, with each population designed and synthesized to be able to detect a particular biomarker. Upon incubation, the mixture is used with nanopore measurements, with recordings of the ionic current through the nanopore. The ionic current recordings are analyzed, which determines the presence and/or concentration of biomarkers in the sample.
Original languageEnglish (US)
U.S. patent number10900067
StatePublished - Jan 26 2021


Dive into the research topics of 'Nucleic acid nanoparticles for analyte detection'. Together they form a unique fingerprint.

Cite this